NW Biotherapeutic Challenges Cancer With DC-Vax - Presented by: The Aol. On Network

05/01/13 Northwest Biotherapeutic's CEO, Linda Powers, discusses the company's DCVax® technology and weighs in on regulatory challenges in the industry.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
MSFT $ 47.87 4.53 ▲ 10.45%
PBR $ 9.99 0.59 ▲ 6.28%
VALE $ 7.92 0.80 ▲ 11.24%
CMCSA $ 59.64 0.41 ▲ 0.69%
AAPL $ 130.28 0.61 ▲ 0.47%
T $ 34.01 0.22 ▼ 0.64%
XRX $ 11.99 1.15 ▼ 8.75%
BAC $ 15.64 0.05 ▼ 0.32%

As of 4/24/2015, 04:15 PM